Naltrexone for 3 or 12 months did not reduce drinking in alcohol dependence [PDF]
Jonathan Chick
openalex +1 more source
ABSTRACT Background & Aims Primary Biliary Cholangitis (PBC) is a chronic autoimmune liver disease characterised by bile duct destruction, leading to cholestasis and fibrosis. Despite therapeutic advancements, gaps remain in diagnostic standardisation, treatment response evaluation, and patient‐centred care. This study aimed to develop consensus‐driven
Domenico Alvaro+11 more
wiley +1 more source
Depot naltrexone: long-lasting antagonism of the effects of heroin in humans [PDF]
Sandra D. Comer+5 more
openalex +1 more source
A Pharmacokinetic and Pharmacodynamic Drug Interaction Study of Acamprosate and Naltrexone [PDF]
Barbara J. Mason+7 more
openalex +1 more source
Naltrexone for 3 or 12 months in addition to psychosocial counselling did not reduce drinking in alcohol dependence [PDF]
Jonathan Chick
openalex +1 more source
Experiences with an Outpatient Relapse Program (Community Reinforcement Approach) Combined with Naltrexone in the Treatment of Opioid-Dependence: Effect on Addictive Behaviors and the Predictive Value of Psychiatric Comorbidity [PDF]
Hendrik G. Roozen+2 more
openalex +1 more source
Quantitative autoradiography of adenosine receptors in brains of chronic naltrexone‐treated mice [PDF]
Alexis Bailey+3 more
openalex +1 more source
Long-term response to naltrexone in polycystic ovary syndrome? [PDF]
Angelo Cagnacci, Anna Maria Paoletti
openalex +1 more source
Therapeutic Uses and Efficacy of Low-Dose Naltrexone: A Scoping Review. [PDF]
Leiber KK, Parker RW.
europepmc +1 more source